| Filed On | Filing |
|---|---|
| 23 Jan 2020 |
Form 4/A: Wilson Dow R, Director
Holds 79,205 shares of Common Stock |
| 19 Sep 2017 |
Form 4/A: Kennedy Kolleen T, EVP and Pres. Oncology Sys.
Received 933 shares by exercise or conversion ($76.5K) |
| 19 Sep 2017 |
Form 4/A: Kennedy Kolleen T, EVP and Pres. Oncology Sys.
Received 1,088 shares by exercise or conversion ($73K) |
| 19 Sep 2017 |
Form 4/A: Wilson Dow R, Director
Received 15,059 shares by exercise or conversion ($771K) |
| 10 Jul 2014 |
Form 4/A: Kennedy Kolleen T, SVP and Pres. Oncology Sys.
Received 1,416 shares by exercise or conversion ($90.5K) |
| 21 Nov 2013 |
Form 4/A: Verhoef Clarence R, SVP, Finance, Corp Controller
Granted 4,039 Restricted Stock Units |
| 08 Nov 2011 |
Form 4/A: Finney Elisha W, SVP, Finance and CFO
Received 10,000 shares by exercise or conversion ($399K) |
| 17 Sep 2008 |
Form 4/A: Levy Richard M, Director
Sold 30,000 shares ($1.87M) |
| 05 Jun 2008 |
Form 4/A: Guertin Timothy E, President and CEO
Received 50,000 shares by exercise or conversion ($818K) |
Loading...